Excessive complement activation and genetic variants in the complement alternative pathway (AP) compounds [Factor H (FH), Factor I (FI), and Complement C3 (C3)] are widely accepted as a contributor to AMD. The gene discussed is C3; the disease is age-related macular degeneration.